Literature DB >> 5688081

Immunochemical studies on the specificity of cellular hypersensitivity. The in vitro inhibition of peritoneal exudate cell migration by cehmically defined antigens.

J R David, S F Schlossman.   

Abstract

The immunochemical specificity of antigen-induced inhibition of peritoneal exudate cell migration was studied in animals sensitized to chemically defined alpha,DNP(Lys)(18) peptides. It was shown that sensitized peritoneal exudate cells could discriminate between various DNP-oligolysines. Only immunogenic members of the homologous series of alpha,DNP-L-lysines equal to or larger in size than the heptamer inhibited the migration of specifically sensitized peritoneal exudate cells. In contrast, nonimmunogenic alpha,DNP-L-lysines, a D-lysine containing stereoisomer of alpha,DNP L(Lys)(9) (alpha,DNP-L(4)DL(4)) and (Lys)(9)epsilon, DNP were not inhibitory to the migration of peritoneal exudate cells derived from animals immunized to alpha,DNP(Lys)(18). The exquisite specificity of the in vitro reaction of sensitized cells with antigen contrasts with the previously observed in vivo or in vitro specificity of anti-alpha,-DNP(Lys)(n) antibody, but parallels the specificity of the in vivo delayed or anamnestic response. These results suggest the presence of a still undefined but highly specific binding site, which functions as the cellular receptor for antigen on the sensitized lymphoid cell or on some "processing" cell.

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 5688081      PMCID: PMC2138577          DOI: 10.1084/jem.128.6.1451

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  12 in total

1.  In vitro cell migration as a model for delayed hypersensitivity.

Authors:  M GEORGE; J H VAUGHAN
Journal:  Proc Soc Exp Biol Med       Date:  1962-11

2.  The specificity of antigen-induced thymidine-2-14C incorporation into lymph node cells frrom sensitized animals.

Authors:  M Stulbarg; S F Schlossman
Journal:  J Immunol       Date:  1968-10       Impact factor: 5.422

3.  Preparation and immunologic properties of stereospecific alpha-dinitrophenylnonalysines.

Authors:  A Yaron; S F Schlossman
Journal:  Biochemistry       Date:  1968-07       Impact factor: 3.162

4.  Delayed hypersensitivity in vitro: its mediation by cell-free substances formed by lymphoid cell-antigen interaction.

Authors:  J R David
Journal:  Proc Natl Acad Sci U S A       Date:  1966-07       Impact factor: 11.205

5.  The immune response. Some unifying concepts.

Authors:  S F Schlossman
Journal:  N Engl J Med       Date:  1967-12-21       Impact factor: 91.245

6.  Desensitization to delayed hypersensitivity reactions. With special reference to the requirement for an immunogenic molecule.

Authors:  S F Schlossman; H Levine
Journal:  J Immunol       Date:  1967-07       Impact factor: 5.422

7.  Immunogenicity of a series of alpha,N-DNP-L-lysines.

Authors:  S F Schlossman; A Yaron; S Ben-Efraim; H A Sober
Journal:  Biochemistry       Date:  1965-08       Impact factor: 3.162

8.  Immunochemical studies on delayed and arthus-type hypersensitivity reactions. I. The relationship between antigenic determinant size and antibody combining site size.

Authors:  S F Schlossman; H Levine
Journal:  J Immunol       Date:  1967-02       Impact factor: 5.422

9.  Mechanism of a reaction in vitro associated with delayed-type hypersensitivity.

Authors:  B R Bloom; B Bennett
Journal:  Science       Date:  1966-07-01       Impact factor: 47.728

10.  Immunochemical studies on the antigenic determinants required to elicit delayed and immediate hypersensitivity reactions.

Authors:  S F Schlossman; S Ben-Efraim; A Yaron; H A Sober
Journal:  J Exp Med       Date:  1966-06-01       Impact factor: 14.307

View more
  25 in total

1.  [Is the macrophage inhibition test suitable for the study of vaccinal tissue immunity?].

Authors:  H Stickl; H Wolfertshofer
Journal:  Infection       Date:  1973       Impact factor: 3.553

Review 2.  The biological activities of soluble lymphocyte products.

Authors:  E Pick; J L Turk
Journal:  Clin Exp Immunol       Date:  1972-01       Impact factor: 4.330

3.  Contact sensitivity in vitro. The production of macrophage inhibition factors from DNCB sensitized lymphocytes by subcellular organelles obtained from DNCB epidermal tissue.

Authors:  K Nishioka; H E Amos
Journal:  Immunology       Date:  1973-09       Impact factor: 7.397

4.  Structural control of immunogenicity. 3. Preparation for and elicitation of anamnestic antibody responses by oligo- and poly-lysines and their DNP derivatives.

Authors:  Y Stupp; W E Paul; B Benacerraf
Journal:  Immunology       Date:  1971-10       Impact factor: 7.397

5.  Migration inhibitory factor and the cellular basis of delayed-type hypersensitivity reactions.

Authors:  B R Bloom; L Jimenez
Journal:  Am J Pathol       Date:  1970-09       Impact factor: 4.307

6.  Cell-mediated immune responses to heterologous and homologous thyroglobulin in guinea-pigs immunized with heterologous thyroid extracts.

Authors:  S Romagnani; M Ricci; A Passaleva; G Biliotti
Journal:  Immunology       Date:  1970-10       Impact factor: 7.397

7.  The immune response to oxidized ferredoxin. I. Specificity of the response to the amino terminal determinant.

Authors:  D S Gregerson; B Kelly; J G Levy
Journal:  Immunology       Date:  1976-09       Impact factor: 7.397

8.  Cell-mediated immune responses to chlamydial antigens in guinea pigs injected with inactivated chlamydiae.

Authors:  G Senyk; M Sharp; D P Stites; L Hanna; H Keshishyan; E Jawetz
Journal:  Med Microbiol Immunol       Date:  1980       Impact factor: 3.402

9.  Role of in vitro and in vivo tests of hypersensitivity in beryllium workers.

Authors:  C D Price; W J Williams; A Pugh; D H Joynson
Journal:  J Clin Pathol       Date:  1977-01       Impact factor: 3.411

10.  Antigen recognition: in vitro studies on the specificity of the cellular immune response.

Authors:  S F Schlossman; J Herman; A Yaron
Journal:  J Exp Med       Date:  1969-11-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.